| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Institute of Clinical Chemistry and Laboratory Medicine, Westfälische Wilhelms-Universität, 48149 Münster, Germany [B. B., R. J., C. G., S. H., G. A.]; Institute of Immunology, University Witten/Herdecke, 58448 Witten, Germany [C. G., K. S. Z.]and; Clinic and Policlinic of Urology, Westfälische Wilhelms-Universität, 48149 Münster, Germany [O. B., A. S.]
The detection of blood-borne prostate cancer (PCA) cells may help with clinical staging and the further understanding of PCA metastases. We discovered prostate-specific antigen (PSA)-positive stained but not PSA mRNA-expressing blood cells by means of cell sorting and PSA reverse transcription-PCR in patients. Therefore, we developed a cytokeratin immunomagnetic method to isolate PSA-positive epithelial cells from the circulating blood of PCA patients. We obtained blood-borne single cells from 6 of 10 PCA patients and clustered cells from 8 of 10 PCA patients. Patients with benign prostate hyperplasia tested negative for cell clusters. The reported isolation method yielded prostate-derived cells or clusters of them from PCA-diagnosed patients.
1 Supported in part by the Fritz-Bender Foundation, Munich.
2 To whom requests for reprints should be addressed.
Received 7/ 3/96. Accepted 8/27/96.
This article has been cited by other articles:
![]() |
J. Wels, R. N. Kaplan, S. Rafii, and D. Lyden Migratory neighbors and distant invaders: tumor-associated niche cells Genes & Dev., March 1, 2008; 22(5): 559 - 574. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Danila, G. Heller, G. A. Gignac, R. Gonzalez-Espinoza, A. Anand, E. Tanaka, H. Lilja, L. Schwartz, S. Larson, M. Fleisher, et al. Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer Clin. Cancer Res., December 1, 2007; 13(23): 7053 - 7058. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Simper-Ronan, K. Brilliant, D. Flanagan, M. Carreiro, H. Callanan, E. Sabo, and D. C. Hixson Cholangiocyte marker-positive and -negative fetal liver cells differ significantly in their ability to regenerate the livers of adult rats exposed to retrorsine Development, November 1, 2006; 133(21): 4269 - 4279. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Schmidt, G. DeAngelis, E. Eltze, I. Gockel, A. Semjonow, and B. Brandt Asynchronous Growth of Prostate Cancer Is Reflected by Circulating Tumor Cells Delivered from Distinct, Even Small Foci, Harboring Loss of Heterozygosity of the PTEN Gene. Cancer Res., September 15, 2006; 66(18): 8959 - 8965. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Wulfing, J. Borchard, H. Buerger, S. Heidl, K. S. Zanker, L. Kiesel, and B. Brandt HER2-Positive Circulating Tumor Cells Indicate Poor Clinical Outcome in Stage I to III Breast Cancer Patients. Clin. Cancer Res., March 15, 2006; 12(6): 1715 - 1720. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Meng, D. Tripathy, E. P. Frenkel, S. Shete, E. Z. Naftalis, J. F. Huth, P. D. Beitsch, M. Leitch, S. Hoover, D. Euhus, et al. Circulating Tumor Cells in Patients with Breast Cancer Dormancy Clin. Cancer Res., December 15, 2004; 10(24): 8152 - 8162. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-L. Gao, S. K. Rawal, L. Sun, A. Ali, R. R. Connelly, L. L. Banez, I. A. Sesterhenn, D. G. Mcleod, J. W. Moul, and S. Srivastava Diagnostic Potential of Prostate-specific Antigen Expressing Epithelial Cells in Blood of Prostate Cancer Patients Clin. Cancer Res., July 1, 2003; 9(7): 2545 - 2550. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hegewisch-Becker, K. Braun, M. Otte, A. Corovic, D. Atanackovic, A. Nierhaus, D. K. Hossfeld, and K. Pantel Effects of Whole Body Hyperthermia (41.8{degrees}C) on the Frequency of Tumor Cells in the Peripheral Blood of Patients with Advanced Malignancies Clin. Cancer Res., June 1, 2003; 9(6): 2079 - 2084. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Fehm, A. Sagalowsky, E. Clifford, P. Beitsch, H. Saboorian, D. Euhus, S. Meng, L. Morrison, T. Tucker, N. Lane, et al. Cytogenetic Evidence That Circulating Epithelial Cells in Patients with Carcinoma Are Malignant Clin. Cancer Res., July 1, 2002; 8(7): 2073 - 2084. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Ringel, P. L. Balducci-Silano, J. S. Anderson, C. A. Spencer, J. Silverman, Y. H. Sparling, G. L. Francis, K. D. Burman, L. Wartofsky, P. W. Ladenson, et al. Quantitative Reverse Transcription-Polymerase Chain Reaction of Circulating Thyroglobulin Messenger Ribonucleic Acid for Monitoring Patients with Thyroid Carcinoma J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 4037 - 4042. [Abstract] [Full Text] |
||||
![]() |
K. Pantel, R. J. Cote, and O. Fodstad Detection and Clinical Importance of Micrometastatic Disease J Natl Cancer Inst, July 7, 1999; 91(13): 1113 - 1124. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Y. Liu, L. D. True, L. LaTray, P. S. Nelson, W. J. Ellis, R. L. Vessella, P. H. Lange, L. Hood, and G. van den Engh Cell-cell interaction in prostate gene regulation and cytodifferentiation PNAS, September 30, 1997; 94(20): 10705 - 10710. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |